Linked Life Data

17433423

Source:http://linkedlifedata.com/resource/pubmed/id/17433423

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-5-21
pubmed:abstractText
To determine the ability of a preoperative serum CA125 to predict optimal primary tumor cytoreduction in patients with stage III and IV epithelial ovarian cancer (EOC).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0090-8258
pubmed:author
pubmed:issnType
Print
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
780-3
pubmed:dateRevised
2008-12-12
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer.
pubmed:affiliation
Department of Gynecology Oncology, Vali-Asr Hospital, Tehran University of Medical Sciences, Keshavarz Blvd., Tehran, Iran.
pubmed:publicationType
Journal Article, Retracted Publication, Evaluation Studies